相关实验视频
Updated: Jul 21, 2025

06:27
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
8.3K
在补充介导的血栓性微血管病变中的怀孕:孕产妇和新生儿的结果
Natalja Haninger-Vacariu1, Andreas Gleiss2, Martina Gaggl1
1Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Kidney medicine
|July 26, 2023
概括
患有补充介导的血栓性微血管病变 (cTMA) 的女性可以成功怀孕,诊断后的结果有所改善. 新生儿发育非常出色,支持对有cTMA病史的妇女进行孕前咨询.
科学领域:
- 生殖医学 生殖医学
- 血液学 血液学 血液学
- 产科 产科 产科 产科 产科
背景情况:
- 补充介导的血栓性微血管病变 (cTMA) 是一种罕见的影响血管的疾病.
- 患有cTMA的女性的怀孕结果没有得到充分的记录,因此需要进一步研究以提供知情咨询.
研究的目的:
- 在有cTMA病史的妇女中调查怀孕,分娩和新生儿后果.
- 为了比较妊娠前,期间和cTMA表现后的结果.
主要方法:
- 在维也纳血栓性微血管病患者队列中,对妇女进行了队列研究.
- 混合效应模型被用来分析怀孕结果,根据母亲的年龄和新生儿的性别进行调整.
主要成果:
- 大多数患有cTMA的女性成功怀孕,尽管在诊断前胎儿损失增加,并在怀孕相关的cTMA (P-cTMA) 期间早产.
- 新生儿发育在所有妊娠条件中都非常出色.
- 在CTMA诊断后发生的怀孕中,怀孕和新生儿结局更为有利.
结论:
- 患有cTMA病史的女性可以成功怀孕.
- 在cTMA诊断后,怀孕结果似乎有所改善.
- 怀孕前咨询对于支持cTMA妇女的生殖欲望至关重要.
相关概念视频
Mitral Valve Prolapse III: Nursing Management
17
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
17
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Development of Immunocompetence
347
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
347

